147 related articles for article (PubMed ID: 1706513)
1. DNA flow cytometric study of the hyperplastic and neoplastic canine prostate.
Madewell BR; Deitch AD; Higgins RJ; Marks SL; deVere White RW
Prostate; 1991; 18(2):173-9. PubMed ID: 1706513
[TBL] [Abstract][Full Text] [Related]
2. Significance of abnormal diploid DNA histograms in localized prostate cancer and adjacent benign prostatic tissue.
Deitch AD; Miller GJ; deVere White RW
Cancer; 1993 Sep; 72(5):1692-700. PubMed ID: 7688657
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric DNA ploidy analysis in canine transitional cell carcinoma of urinary bladders.
Clemo FA; DeNicola DB; Carlton WW; Morrison WB; Walker E
Vet Pathol; 1994 Mar; 31(2):207-15. PubMed ID: 8203084
[TBL] [Abstract][Full Text] [Related]
4. Clear cell cribriform hyperplasia of the prostate. Immunohistochemical and DNA flow cytometric study.
Frauenhoffer EE; Ro JY; el-Naggar AK; Ordóñez NG; Ayala AG
Am J Clin Pathol; 1991 Apr; 95(4):446-53. PubMed ID: 1707587
[TBL] [Abstract][Full Text] [Related]
5. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical Expression of Angiogenic Factors by Neoplastic Epithelial Cells Is Associated With Canine Prostatic Carcinogenesis.
Palmieri C
Vet Pathol; 2015 Jul; 52(4):607-13. PubMed ID: 25281650
[TBL] [Abstract][Full Text] [Related]
7. DNA heterogeneity in prostatic adenocarcinoma. A DNA flow cytometric mapping study with whole organ sections of prostate.
O'Malley FP; Grignon DJ; Keeney M; Kerkvliet N; McLean C
Cancer; 1993 May; 71(9):2797-802. PubMed ID: 8467459
[TBL] [Abstract][Full Text] [Related]
8. Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy.
Pollack A; Zagars GK; el-Naggar AK; Gauwitz MD; Terry NH
Cancer; 1994 Apr; 73(7):1895-903. PubMed ID: 7511039
[TBL] [Abstract][Full Text] [Related]
9. The distribution of oestrogen receptors in normal, hyperplastic and neoplastic canine prostate, as demonstrated immunohistochemically.
Grieco V; Riccardi E; Rondena M; Romussi S; Stefanello D; Finazzi M
J Comp Pathol; 2006 Jul; 135(1):11-6. PubMed ID: 16815431
[TBL] [Abstract][Full Text] [Related]
10. DNA heterogeneity determined by flow cytometry in prostatic adenocarcinoma--necessitating multiple site analysis.
Warzynski MJ; Soechtig CE; Maatman TJ; Goldsmith LC; Grobbel MA; Carothers GG; Shockley KF
Prostate; 1995 Dec; 27(6):329-35. PubMed ID: 7501545
[TBL] [Abstract][Full Text] [Related]
11. DNA distribution in the prostate. Normal gland, benign and premalignant lesions, and subsequent adenocarcinomas.
Berner A; Danielsen HE; Pettersen EO; Fosså SD; Reith A; Nesland JM
Anal Quant Cytol Histol; 1993 Aug; 15(4):247-52. PubMed ID: 7691062
[TBL] [Abstract][Full Text] [Related]
12. Transrectal fine needle aspiration biopsy of the prostate combining cytomorphologic, DNA ploidy status and cell cycle distribution studies.
Paz-Bouza JI; Orfao A; Abad M; Ciudad J; Garcia MC; Lopez A; Bullon A
Pathol Res Pract; 1994 Aug; 190(7):682-9. PubMed ID: 7528913
[TBL] [Abstract][Full Text] [Related]
13. DNA ploidy and proliferation heterogeneity in human prostate cancers.
Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
[TBL] [Abstract][Full Text] [Related]
14. Methodologic sources of errors in image and flow cytometric DNA assessments of the malignancy potential of prostatic carcinoma.
Falkmer UG
Hum Pathol; 1992 Apr; 23(4):360-7. PubMed ID: 1563736
[TBL] [Abstract][Full Text] [Related]
15. DNA and S-phase fraction analysis by flow cytometry in prostate cancer. Clinicopathologic implications.
Tinari N; Natoli C; Angelucci D; Tenaglia R; Fiorentino B; Di Stefano P; Amatetti C; Zezza A; Nicolai M; Iacobelli S
Cancer; 1993 Feb; 71(4):1289-96. PubMed ID: 8435806
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of p53, but not Rb, is involved in canine prostatic carcinogenesis.
Pagliarone S; Frattone L; Pirocchi V; Della Salda L; Palmieri C
Res Vet Sci; 2016 Apr; 105():195-9. PubMed ID: 27033932
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric DNA analysis of ulcerative colitis using paraffin-embedded biopsy specimens: comparison with morphology and DNA analysis of fresh samples.
Hartmann DP; Montgomery EA; Carr NJ; Gupta PK; Azumi N
Am J Gastroenterol; 1995 Apr; 90(4):590-6. PubMed ID: 7717317
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric DNA analysis of parathyroid tumors with special reference to its diagnostic and prognostic value in parathyroid carcinoma.
Obara T; Fujimoto Y; Hirayama A; Kanaji Y; Ito Y; Kodama T; Ogata T
Cancer; 1990 Apr; 65(8):1789-93. PubMed ID: 1969327
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of DNA ploidy in carcinoma of prostate.
Dejter SW; Cunningham RE; Noguchi PD; Jones RV; Moul JW; McLeod DG; Lynch JH
Urology; 1989 May; 33(5):361-6. PubMed ID: 2711553
[TBL] [Abstract][Full Text] [Related]
20. DNA ploidy in prostate cancer: potential measurement as a surrogate endpoint biomarker.
Lieber MM
J Cell Biochem Suppl; 1994; 19():246-8. PubMed ID: 7529855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
